De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation

Table 1 Summary management strategies

Lifestyle modifications	Dietary modification
	Exercise/ physical activity
	Avoid heavy alcohol consumption
	Benefit with coffee consumption
Pharmacotherapy	No approved drug for MAFLD in post liver transplants patients
Bariatric treatment	Surgery
	Endoscopic
Tailored Immunosuppression	Early taper of steroids
	Decreasing CNIs as possible
	Avoid/cautious use of mTOR inhibitors

CNIs: Calcineurin inhibitors; MAFLD: Metabolic dysfunction-associated fatty liver disease.